{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:21:18Z","timestamp":1790652078513,"version":"4.1.0"},"reference-count":49,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,5]]},"DOI":"10.4269\/ajtmh.20-0184","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T07:01:39Z","timestamp":1589266899000},"page":"894-908","source":"Crossref","is-referenced-by-count":34,"title":["Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo"],"prefix":"10.4269","volume":"103","author":[{"given":"Simon","family":"Sch\u00e4fermann","sequence":"first","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin","family":"Hauk","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Wemakor","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Neci","sequence":"additional","affiliation":[{"name":"Le D\u00e9p\u00f4t Central M\u00e9dico-Pharmaceutique de la 8e CEPAC (DCMP), Bukavu, Democratic Republic of Congo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mutombo","sequence":"additional","affiliation":[{"name":"Le D\u00e9p\u00f4t Central M\u00e9dico-Pharmaceutique de la 8e CEPAC (DCMP), Bukavu, Democratic Republic of Congo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ngah Ndze","sequence":"additional","affiliation":[{"name":"Cameroon Baptist Convention (CBC), Central Pharmacy, Mutengene, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambo","family":"Cletus","sequence":"additional","affiliation":[{"name":"Cameroon Baptist Convention (CBC), Central Pharmacy, Mutengene, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelis","family":"Nyaah","sequence":"additional","affiliation":[{"name":"Presbyterian Church in Cameroon (PCC), Central Pharmacy, Limbe, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyi","family":"Pattinora","sequence":"additional","affiliation":[{"name":"Presbyterian Church in Cameroon (PCC), Central Pharmacy, Limbe, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Wistuba","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Helmle","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"H\u00e4fele-Abah","sequence":"additional","affiliation":[{"name":"German Institute for Medical Mission (Difaem), Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gross","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heide","sequence":"additional","affiliation":[{"name":"Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","volume-title":"The World Medicines Situation 2011. Medicines Prices, Availability and Affordability","year":"2011"},{"key":"b2","volume-title":"The Evolution of Access to Essential Medicines for the Treatment of HIV\/AIDS -Evidence From 2000 to 2015","author":"Wilsdon","year":"2016"},{"key":"b3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4269\/ajtmh.14-0393","article-title":"Responding to the pandemic of falsified medicines","volume":"92","author":"Nayyar","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"b4","volume-title":"Sustainable Development Goal 3. Progress of Goal 3 in 2017","year":"2017"},{"key":"b5","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2214-109X(16)30287-X","article-title":"An epidemic of dystonic reactions in central Africa","volume":"5","author":"Peyraud","year":"2017","journal-title":"Lancet Glob Health"},{"key":"b6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.311.6997.88","article-title":"Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic","volume":"311","author":"Hanif","year":"1995","journal-title":"BMJ"},{"key":"b7","volume-title":"A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products","year":"2017"},{"key":"b8","volume-title":"WHO Global Surveilance and Monitoring System for Substandard and Falsified Medical Products","year":"2017"},{"key":"b9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017","journal-title":"Lancet"},{"key":"b10","doi-asserted-by":"crossref","first-page":"e1609","DOI":"10.1016\/S2214-109X(19)30426-7","article-title":"Global access to quality-assured medical products: the Oxford Statement and call to action","volume":"7","author":"Newton","year":"2019","journal-title":"Lancet Glob Health"},{"key":"b11","doi-asserted-by":"crossref","first-page":"e181662","DOI":"10.1001\/jamanetworkopen.2018.1662","article-title":"Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis","volume":"1","author":"Ozawa","year":"2018","journal-title":"JAMA Netw Open"},{"key":"b12","volume-title":"Seventieth World Health Assembly update","year":"2017"},{"key":"b13","volume-title":"Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa","year":"2011"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e0184165","DOI":"10.1371\/journal.pone.0184165","article-title":"Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab","volume":"12","author":"Petersen","year":"2017","journal-title":"PLoS One"},{"key":"b15","volume-title":"Manual Accompanying the GPHF Minilab\u2122. Volume II. Thin-Layer Chromatographic Tests","year":"2008"},{"key":"b16","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/dta.2420","article-title":"Quality of the antimalarial medicine artemether\u2013lumefantrine in 8 cities of the Democratic Republic of the Congo","volume":"10","author":"Mufusama","year":"2018","journal-title":"Drug Test Anal"},{"key":"b17","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4269\/ajtmh.17-0732","article-title":"The quality of medicines used in children and supplied by private pharmaceutical wholesalers in Kinshasa, Democratic Republic of Congo: a prospective survey","volume":"98","author":"Schiavetti","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12981-017-0147-x","article-title":"Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon","volume":"14","author":"Djobet","year":"2017","journal-title":"AIDS Res Ther"},{"key":"b19","volume-title":"Global Status Report on Noncommunicable Diseases 2014","year":"2014"},{"key":"b20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2213-8587(17)30220-6","article-title":"How to address non-communicable diseases in urban Africa","volume":"5","author":"Hunter-Adams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"b21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijcard.2017.04.099","article-title":"Fighting fake medicines: first quality evaluation of cardiac drugs in Africa","volume":"243","author":"Antignac","year":"2017","journal-title":"Int J Cardiol"},{"key":"b22","doi-asserted-by":"crossref","first-page":"e0227515","DOI":"10.1371\/journal.pone.0227515","article-title":"Availability, prices and affordability of selected antibiotics and medicines against non-communicable diseases in western Cameroon and northeast DR Congo","volume":"15","author":"Sch\u00e4fermann","year":"2020","journal-title":"PLoS One"},{"key":"b23","volume-title":"Guidelines on the Conduct of Surveys of the Quality of Medicines. WHO Technical Report Series No. 996. 2016","year":"2016"},{"key":"b24","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"b25","volume-title":"Liste nationale des medicaments et autres produit pharmaceutiques essentiels 2017","year":"2017"},{"key":"b26","volume-title":"Liste nationale des medicaments essentiels. Revision Mars 2010","year":"2010"},{"key":"b27","doi-asserted-by":"crossref","first-page":"e111812","DOI":"10.1371\/journal.pone.0111812","article-title":"Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon","volume":"9","author":"Jingi","year":"2014","journal-title":"PLoS One"},{"key":"b28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13031-015-0046-5","article-title":"Analyzing Katana referral hospital as a complex adaptive system: agents, interactions and adaptation to a changing environment","volume":"9","author":"Karemere","year":"2015","journal-title":"Confl Health"},{"key":"b29","volume-title":"Primary Health Care Systems (PRIMASYS). Comprehensive Case Study From Cameroon","author":"Ongolo-Zogo","year":"2017"},{"key":"b30","volume-title":"Health Analytical profile: Cameroon\u20132016","year":"2017"},{"key":"b31","doi-asserted-by":"crossref","first-page":"e0207911","DOI":"10.1371\/journal.pone.0207911","article-title":"Quality of medicines in southern Togo: investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors","volume":"13","author":"Sch\u00e4fermann","year":"2018","journal-title":"PLoS One"},{"key":"b32","volume-title":"Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products. WHO Technical Report Series, No. 953, 2009, Annex 2","year":"2009"},{"key":"b33","volume-title":"Drugs Made in Germany. Drug Stability Testing Classification of Countries According to Climatic Zone","author":"Dietz","year":"1993"},{"key":"b34","volume-title":"Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products. WHO Technical Report Series, No. 953, 2015, Annex 2","year":"2015"},{"key":"b35","volume-title":"WHO Expert Committee on Specifications for Pharmaceutical Preparations Fifty-Second Report. WHO Technical Report Series No. 1010","year":"2018"},{"key":"b36","volume-title":"Medical Product Alert N\u00b0 2\/2018. Falsified \u201cAugmentin\u201d Circulating in Cameroon","year":"2018"},{"key":"b37","volume-title":"World Health Organization. Model List of Essential Medicines. 21st List. 2019","year":"2019"},{"key":"b38","volume-title":"Medical Product Alert N\u00b0 4\/2017. Falsified Penicillin V Circulating in Cameroon","year":"2017"},{"key":"b39","volume-title":"Saunders Handbook of Veterinary Drugs. Small and Large Animal","author":"Pappich","year":"2016"},{"key":"b40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.14-0535","article-title":"Monitoring the quality of medicines: results from Africa, Asia, and South America","volume":"92","author":"Hajjou","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"b41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake anti-malarials: start with the facts","volume":"15","author":"Kaur","year":"2016","journal-title":"Malar J"},{"key":"b42","first-page":"1124","article-title":"Low prevalence of substandard and falsified antimalarial and antibiotic medicines in public and faith-based health facilities of southern Malawi","volume":"96","author":"Khuluza","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"b43","volume-title":"WHO List of Prequalified Medicinal Products, Medicines and Finished Pharmaceutical Products","year":"2020"},{"key":"b44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1057\/jphp.2013.53","article-title":"A quiet revolution in global public health: the World Health Organization\u2019s prequalification of medicines programme","volume":"35","author":"t Hoen","year":"2014","journal-title":"J Public Health Policy"},{"key":"b45","first-page":"165","article-title":"Comparative study of epidemiological and anthropological aspects of diabetes and hypertension in Cameroon","volume":"5","author":"Tsabang","year":"2016","journal-title":"J For Res"},{"key":"b46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/inthealth\/ihw021","article-title":"Non-communicable diseases in sub-Saharan Africa: understanding the drivers of the epidemic to inform intervention strategies","volume":"8","author":"Nyirenda","year":"2016","journal-title":"Int Health"},{"key":"b47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpba.2016.03.018","article-title":"Characterization of drug authenticity using thin-layer chromatography imaging with a mobile phone","volume":"125","author":"Yu","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"b48","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4269\/ajtmh.18-0127a","article-title":"Letter to the editor on previously published GPHF-minilab assessment","volume":"98","author":"J\u00e4hnke","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b49","doi-asserted-by":"crossref","first-page":"e000725","DOI":"10.1136\/bmjgh-2018-000725","article-title":"Field detection devices for screening the quality of medicines: a systematic review","volume":"3","author":"Vickers","year":"2018","journal-title":"BMJ Glob Health"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:06:39Z","timestamp":1611767199000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8,5]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0184","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}